
Marksans Pharma Limited has informed the Exchange about press release dated 11-Oct-2022 titled Marksans acquires capacity from Tevapharm India; Plans to double its manufacturing footprint to bolster the growth
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange about press release dated 11-Oct-2022 titled Marksans acquires capacity from Tevapharm India; Plans to double its manufacturing footprint to bolster the growth
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma